Aroa Biosurgery Limited announced that it has signed a contract extension for its Myriad products with a US GPO, HealthTrust. The contract extension adds AROA's Myriad Matrix and Myriad Morcells products to its pre-existing purchase agreement with HealthTrust for Endoform products. HealthTrust's members will be able to access the Myriad products from 8 October 2021. This extension is for a period of approximately 3 years (expiring on 31 July 2024).